Pancreatic neuroendocrine tumors Doctors Abroad — Page 3

Prof. Köstler is an internationally recognized authority in precision oncology, focusing on targeted cancer therapies and immunotherapy at Wiener Privatklinik.

• Over two decades of expertise in internal medicine and oncology
• Former Deputy Head of Oncology at the Medical University of Vienna
• Specializes in breast cancer, gynecologic malignancies, and solid tumors
• Focuses on biomarker development and individualized systemic cancer therapy

Dr. Inna Ospovat is a leading specialist in Lutetium-177 PRRT, pioneering this breakthrough therapy globally.

• Heads the nuclear therapy department at Ichilov – one of few centers offering this treatment
• Specialized in oncology and radiation therapy at Hadassah University Hospital
• Member of ASTRO and Israel Society of Clinical Oncology
• Expert in radiobiological treatments for gastrointestinal tumors

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over 2016 years of experience of experience in oncology
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Specializing in virotherapy – a cutting-edge immunology field – Dr. Jaunalksne brings over 49 years of experience of experience to pancreatic neuroendocrine tumor treatment.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focused on integrating immunotherapy approaches for better outcomes

Dr. Auala Hubert is Head of the Gastrointestinal Cancer Center at Hadassah Medical Center – specializing in digestive system cancers.

• 36 years of experience of experience as a medical oncologist and radiotherapist
• Trained in psychology at Hebrew University – adds a human touch to cancer care
• Board certified in both Oncology and Radiotherapy
• Active member of Israel's Committee for Gastrointestinal Cancer

Professor Gul Alco specializes in radiation oncology with over two decades of experience, currently at Istanbul Medipol University.

• Professor in Radiation Oncology since 2021
• Residency completed at Kadir Has University
• Extensive experience in treating pancreatic neuroendocrine tumors
• Expertise in advanced radiation therapy techniques

Assoc. Prof. Nail Paksoy specializes in pancreatic neuroendocrine tumors, backed by ESMO board certification and extensive research in oncology.

• Medical Oncology fellowship at Istanbul University Oncology Institute
• Published research on treatment strategies for neuroendocrine tumors
• Participated in clinical trials focusing on advanced cancer therapies
• Academic role at Istanbul Medipol University

Dr. Muzaffer Al specializes in laparoscopic surgery for pancreatic neuroendocrine tumors at Büyük Anadolu Hospitals.

• Trained in advanced laparoscopic and oncological cancer surgery at Istanbul University
• Specialized in laparoscopic antireflux surgery
• Experienced in laparoscopic bariatric surgery

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Alemdar specializes in pancreatic neuroendocrine tumors at Medical Park Antalya Hospital Complex, with extensive training in medical oncology.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University, a leading medical institution
• Works at a JCI-accredited hospital with advanced oncology units

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Volkan Kinas specializes in pancreatic surgery, focusing on neuroendocrine tumors at Büyük Anadolu Hospitals.

• Specialized in both pancreatic and oncological surgery
• Handles complex cases involving bile duct and gastric cancer
• Experienced in bariatric metabolic surgeries
• Works within a multidisciplinary team for comprehensive care